Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LFSC

F/m Emerald Life Sciences Innovation ETF

Feb 06 • 04:00PM ET

35.34

+1.13 3.31 %

Financial • Exchange Traded Fund • USA • NASD

Held by: NMBL

Category	US Equities - Factor & Thematic	Asset Type	Equities (Stocks)	Tags	Developed	Return% 1Y	29.69%	Total Holdings	39	Perf Week	-0.85%
Sponsor	F/m Investments	ETF Type		Tags	equity	Return% 3Y	-	AUM	86.12M	Perf Month	-4.57%
Fund Family		Bond Type		Tags	innovation	Return% 5Y	-	NAV/sh		Perf Quarter	12.40%
Index	-	Average Maturity		Tags	healthcare	Return% 10Y		52W High	39.60 -10.76%	Perf Half Y	44.96%
Index Weighting		Commodity Type		Tags	biotechnology	Return% SI		52W Low	18.78 88.17%	Perf YTD	-3.49%
Active/Passive		Quant Type		Tags	medical	Flows% 1M	-0.43%	Volatility	1.99% 1.64%	Perf Year	45.49%
Dividend TTM	-	ESG Type		Tags	pharmaceutical	Flows% 3M	7.06%	ATR (14)	0.80	Perf 3Y	-
Dividend Ex-Date	-	Dividend Type		Sector/Theme		Flows% YTD	-0.77%	RSI (14)	44.20	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	1.43	Perf 10Y	-
Expense	0.54%	Growth/Value		SMA20	-1.84%	Flows% 3Y		Rel Volume	0.15	Prev Close	34.21
Inverse/Leveraged		Market Cap		SMA50	-4.79%	Flows% 5Y		Avg Volume	6.33K	Price	35.34
IPO	Oct 31, 2024	Option/Short	No / Yes	SMA200	20.70%	Trades		Volume	962	Change	3.31%

Jan-22-26 12:51PM	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer (Benzinga)
Jan-14-26 06:44AM	Travere Stock Slips After FDA Delays Review Of Key Kidney Drug (Benzinga)
Dec-31-25 11:00AM	Best-Performing Active ETFs of 2025 (Zacks)
Feb-04-25 10:15AM	Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference (Business Wire)
Oct-31-24 07:30AM	Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC) (Business Wire)

F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

open in yahoo | open in marketwatch | open in google

LFSC

F/m Emerald Life Sciences Innovation ETF

Upgrade your FINVIZ experience